Clinical Trial Update: Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting completion of a study evaluating cabotegravir (GSK1265744) for its effects on cardiac conduction in people with human immunodefic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED